Why might triiodothyronine (T3) be elevated in Graves disease while thyroxine (T4) and thyroid‑stimulating hormone (TSH) remain normal?

T3-Predominant Graves' Disease: Early or Mild Hyperthyroidism

In Graves' disease, isolated T3 elevation with normal T4 and TSH typically represents early-stage or mild hyperthyroidism, termed "T3-toxicosis," where the thyroid gland preferentially secretes T3 over T4 due to enhanced intrathyroidal metabolism. 1

Pathophysiology

The mechanism behind isolated T3 elevation in Graves' disease involves several key factors:

• Enhanced thyroid secretion: Approximately one-third of T3 production in Graves' disease comes directly from thyroid secretion (versus ~20% in normal individuals), with the remainder from peripheral T4-to-T3 conversion 2

• Increased intrathyroidal T4 5'-deiodinase activity: The thyroid gland itself converts more T4 to T3 before secretion, mediated by high levels of TSH receptor antibodies 3, 4

• Accelerated iodine metabolism: Patients with T3-predominant disease show higher thyroid peroxidase activity, lower thyroglobulin content, and rapid iodine turnover (radioactive iodine uptake peaks at 3 hours then decreases by 24 hours, opposite to normal pattern) 4

• Higher TSH receptor antibody activity: These patients typically have significantly elevated TSH receptor antibody levels compared to those with proportionate T3/T4 elevation 3, 4

Clinical Significance

This pattern carries important prognostic implications:

• T3-predominant Graves' disease (T3/T4 ratio >20 ng/mcg) is associated with poor response to antithyroid drug therapy and high relapse rates (90% in one study) 3

• These patients rarely achieve long-term remission with medical management alone 3

• The condition may progress to overt hyperthyroidism with both T3 and T4 elevation

Diagnostic Approach

When you encounter suppressed TSH with isolated T3 elevation:

1. Confirm the diagnosis: Repeat TSH with free T4 and total T3 (or free T3) within 2-4 weeks 5

2. Calculate the T3/T4 ratio: A ratio >20 (ng/mcg) suggests T3-predominant disease and helps differentiate Graves' disease from destructive thyroiditis, where the ratio is typically <20 6

3. Measure TSH receptor antibodies: Elevated levels confirm Graves' disease and correlate with disease severity 4

4. Consider radioactive iodine uptake: If diagnosis is uncertain, RAIU will be elevated/normal in Graves' disease (unless recent iodine exposure) versus suppressed in thyroiditis 1

Critical Caveat

If TSH is truly normal (not just low-normal), the patient is almost never hyperthyroid 1. In this scenario, consider:

• Euthyroid hyperthyroxinemia from binding protein abnormalities (TBG excess, familial dysalbuminemia)
• TSH-producing pituitary adenoma (check alpha-subunit, obtain pituitary MRI)
• Thyroid hormone resistance (check family history, genetic testing)
• Assay interference from heterophilic antibodies

The key distinction is between low-normal or suppressed TSH (which can occur in early T3-toxicosis) versus truly normal TSH (which essentially excludes primary hyperthyroidism).